- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.05. | Neuralink wins FDA breakthrough nod for treating speech impairment | ||
| 01.05. | Stryker posts strong Q1 results, expects $200M tariff costs | ||
| 01.05. | Baxter beats the Street in Q1, increases full-year guidance | ||
| 01.05. | Facing up to $300M in tariff costs, Cardinal Health lays off employees | ||
| 01.05. | Facing up to $300M in tariff costs, Cardinal Heath lays off employees | ||
| 01.05. | Element Sciences earns FDA premarket approval for wearable defibrillator patch | ||
| 01.05. | Intuitive earns expanded FDA nod for da Vinci single port system | ||
| 01.05. | Resmed acquires virtual diagnostics company VirtuOx | ||
| 01.05. | Edwards wins FDA nod for TAVR in aortic stenosis without symptoms | ||
| 01.05. | Precision Neuroscience strengthens leadership following FDA clearance for BCI tech | ||
| 01.05. | BD posts mixed Q2, adjusts guidance for tariff impact | ||
| 30.04. | Spark Biomedical closes $15M Series A for wearable neurostim | ||
| 30.04. | How Zimmer Biomet CEO Ivan Tornos recruited Arnold Schwarzenegger - a mostly true story from DeviceTalks Boston | ||
| 30.04. | Surmodics stock takes another hit on Q2 miss and 2025 guidance | ||
| 30.04. | Former Medtronic exec Rob ten Hoedt named chair at tricuspid repair company Coramaze | ||
| 30.04. | Transverse Medical raises $10M in Series B2 round | ||
| 30.04. | Smith+Nephew stock rises on Q1 results | ||
| 30.04. | The top cardiac tech stories out of HRS 2025 | ||
| 30.04. | Medtronic study backs automated neuromod for overactive bladder | ||
| 30.04. | GE HealthCare lowers its EPS guidance amid tariffs | ||
| 30.04. | Teleflex wins FDA nod for expanded hemostatic device indications | ||
| 30.04. | Chipiron raises $17M to support miniaturized MRI scanner | ||
| 29.04. | iCad, Microsoft collab on mammography access | ||
| 29.04. | Insulet earns insulin patch pump patent victory against EOFlow with permanent injunction | ||
| 29.04. | HeartBeam 12-lead ECG meeds study endpoints |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .